STAQ Pharma Inc. recalled Ketamine Hydrochloride 50mg/5 mL syringes on October 9, 2025. The recall affects products with incorrect or missing lot and expiration dates. The FDA classified this recall as Class III due to potential risks to patient safety.
Labeling: Incorrect or Missing Lot and/or Exp Date
Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is Ketamine Hydrochloride, 50mg/5 mL injection for IV use, packaged in 50 mL syringes. The affected lot number is 25156673A, with an expiry date of February 2, 2026. This product was distributed nationwide in the U.S.
The recall stems from incorrect or missing labeling, specifically related to lot numbers and expiration dates. Improper labeling can lead to the use of expired or incorrect medication, posing serious health risks.
Stop using the recalled product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for further guidance. A notification letter will be sent to affected consumers and healthcare providers.
For more information, call STAQ Pharma, Inc. at the contact number provided on the product packaging or visit the FDA recall page at the provided URL.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Honda recalls 2025 CR-V Hybrid vehicles sold through Honda dealers nationwide after finding an improperly installed fuel feed hose that may leak. The recall is identified by Honda as TLS. Dealers will replace the fuel feed hose and install a new connector cover at no charge. Owners should contact Honda at 1-888-234-2138 for service.
Volkswagen Group of America recalls 2023-2025 Atlas, Atlas Cross Sport and 2023-2024 ID.4 models for loose bolts in the chassis, brake system and suspension. The potential consequence is loss of vehicle control and a crash risk. Owners should stop driving the vehicle and contact a dealer for inspection; recall letters were mailed on July 25, 2025.
Mercedes-Benz USA is recalling certain 2024 GLE 350 4MATIC, 2025 GLE 450e 4MATIC, and additional models sold through its dealer network. The issue involves a multi-purpose camera and rearview mirror that may detach from the windshield. Dealers will replace the windshield and reinstall the camera and mirror at no charge.
Mazda North American Operations recalls 2024-2025 Mazda3 and CX-30 vehicles after SAS units may deactivate airbags due to a low battery condition. Dealers will reprogram the SAS unit or replace it at no charge. Owner notification letters were mailed July 24, 2025.
Kia America, Inc. recalled certain 2023-2025 K5 vehicles on April 7, 2027. The recall involves rear window trim pieces that may loosen and detach, creating a road hazard. Owners should contact Kia for inspection and potential replacement of affected parts.
Kia America, Inc. is recalling 2023-2025 Kia Telluride SUVs sold through Kia dealers nationwide after interim notices warned that door belt molding trim can delaminate and detach. A detached trim piece can become a road hazard for other vehicles and increase the risk of a crash. Owners should contact Kia customer service at 800-333-4542 for inspection and repair.
Ford Motor Company recalled certain 2024-2025 Expedition vehicles due to a misaligned engine cup plug. This defect can lead to rapid oil leaks, increasing the risk of engine stalls and fires. The recall affects models with 3.5L GTDI engines, with notifications mailed on May 22, 2025.
Volkswagen Group of America, Inc. recalled certain 2024-2025 Audi Q4 E-Tron models on April 2, 2027. The on-board charger may fail, leading to a loss of drive power. This defect increases the risk of a crash.